106.00
+1.92%
Close of 9 Nov 2026, in TWD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Bioteque
Its shares trade on Taipei Exchange under the ticker 4107.TWO. It has been listed since 2 January 2002. In the fiscal year to 31 December 2025, it reported revenue of TWD 2.14bn and net income of TWD 539.2m. At that date it held total assets of TWD 4.66bn and shareholders' equity of TWD 3.61bn.
Bioteque Corp. is engaged in manufacturing and trading of medical supplies and equipment such as medical plastic tube, medical extended tubes and test apparatus. The company is headquartered in Taipei City, Taipei. The company went IPO on 2002-01-02. The firm is also engaged in the importing and exporting of medical equipment. The Company’s primary products include thermoplastic urethane (TPU) tubes, angiography catheters, blood loop tubes, puncture needles, medical use soft bags, transfusion sets, surgery drainage tubes, urethral catheters, precise measuring cylinders, as well as other medical supplies and components. The firm mainly distributes its product within domestic market and to overseas markets, including the rest of Asia, the Americas, Europe and Africa.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 2 Jan 2002
- Website
- bioteq.com.tw ↗
Leadership
Pay as last reported
- Mr. Ming-Zhong LiChairman of the Board, since 1996TWD 10.3m
- Ms. Jingyi CaiVice Chairman of the Board, Deputy General Manager, since 2019TWD 5.3m
- Yizhong HuangChief Financial Officer, Head of Finance, Director
- Mr. Jin-Long LinGeneral Manager, since 1999TWD 6.7m
- Mr. Yi-Xun LiSenior Deputy General Manager, Director, since 2007TWD 4.3m
- Peizhi ZhongHead of Accounting, Corporate Governance Officer, since 2024
- Mr. Jing-Zhong ChenDirector
- Ms. Ming Yeh ChengDirectorTWD 1.1m
- Mr. Yao-Ren HoDirectorTWD 1.1m
- Mr. Zhong-Kai HongDirector
- Ms. Hung-Ying LeeDirector
- Mr. Hsu-Yuan LiDirector
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Bioteque Corp manufactures diverse medical supplies like TPU tubes and catheters.
- The company distributes products to overseas markets in Asia, the Americas, Europe, and Africa.
- Bioteque Corp has been publicly traded since its IPO in 2002.
Weaknesses
- The firm primarily focuses on domestic distribution alongside its international reach.
- Bioteque Corp operates in the competitive health care industry sector.
- The company relies on importing and exporting medical equipment for its business.
Opportunities
- Bioteque Corp can expand its trading of medical plastic tubes and test apparatus.
- The firm may grow its presence in the Americas and Africa markets.
- Bioteque Corp could increase sales of precision measuring cylinders and surgery drainage tubes.
Threats
- Competition exists within the health care industry for medical equipment suppliers.
- Bioteque Corp faces risks from fluctuations in international trade regulations.
- The company must maintain quality standards for imported and exported medical supplies.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.